Deepa Halaharvi, DO
Surgery · Columbus, OHNPI 1043485253
Payments from drug & device makers
Across 48 payments — averaging $346.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Hologic Inc$12K
- Novartis$2K
- Stryker$1K
- Endomagnetics Ltd$729
- Dilon Technologies, Inc.$218
- Integra Lifesciences Corporation$123
- plus $812 from 9 others
What the payments were for
- Consulting fees$10,57564%
- Travel & lodging$3,48321%
- Food & beverage$2,51015%
- Education$720%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Hologic Inc | 13 | $11,740 |
| Novartis | 2 | $1,648 |
| Stryker | 14 | $1,369 |
| Endomagnetics Ltd | 6 | $729 |
| Dilon Technologies, Inc. | 2 | $218 |
| Integra Lifesciences Corporation | 2 | $123 |
| Sanofi | 1 | $121 |
| Merck | 1 | $117 |
| Solventum Corporation | 1 | $117 |
| Medical Device Business Services, Inc. | 1 | $112 |
| Innovation Technologies Inc | 1 | $100 |
| Axogen | 1 | $81 |
| Conmed Corporation | 1 | $76 |
| Genentech USA, Inc. | 1 | $72 |
| Covidien LP | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BioZorb$6,973
- TRIDENT SPECIMEN RADIOGRAPHY SYSTEM$3,464
- KISQALI$1,575
- Localizer$1,498
- EIKON$929
- Magseed$643
- Magtrace$643
- HemoBlast Bellows$146
- LIBTAYO$121
- KEYTRUDA$117
- PREVENA$117
- SURG - NEPTUNE$116
- Mega Power$112
- Mega Soft$112
- Mega Vac$112
- Irrisept$100
How this compares
$16,640 in reported general payments places this provider in the 85th percentile of 988 surgery providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 96 | $988 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 60 | $312 |
| Cephalexin | 18 | $120 |
| Clindamycin Hcl | 15 | $95 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $73 |
| Furosemide | 14 | $26 |
| Gabapentin | 23 | $24 |
Paid to pharmacies, not to this prescriber.
Other surgery in Columbus
- Michael MearaColumbus$868K
- Marshall SpaldingColumbus$450K
- Michelle KincaidColumbus$262K
- Vimal NarulaColumbus$218K
- Benjamin PouloseColumbus$192K
- Thomas SonnanstineColumbus$144K
- Kyle PerryColumbus$109K
- Mark GazallColumbus$52K
- Bradley NeedlemanColumbus$49K
- Jonathan ThompsonWest Chester$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.